The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

IFPMA’s Director-General, Thomas Cueni, outlines how companies worldwide can foster long-term tech transfer partnerships.

Researchers explain how they used video games to explore human behavior when it comes to producing pharma products.

Companies must adapt to the requirements of rigorous remote inspections.

Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.

Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

We talk to Roche’s Paulo Fontoura about Evrysdi and its impact on patient lives.

Find out how nanotechnology can overcome challenges in drug delivery to the eye.